Asthma

A next generation propellant for asthma inhalers could be a better alternative for the planet.

Enquire Now

Sex
I consent to be contacted via text, email or phone(Required)
How would you like to be contacted?
Where did you hear about us?

We use this to understand which recruitment methods are working.
Privacy Notice we will only use your personal information for administration purposes and to provide information on upcoming medical trials relevant to you. Please read our full Privacy Notice and accept - Click Here
I have read Ormeau Clinical Trials Privacy Notice and agree(Required)

Trial Overview

The study is to evaluate the safety and efficacy of an investigational asthma inhaler that uses a new climate friendly alternative propellant. If you use an inhaler with steroid medication for mild to moderate asthma, help us study an inhaler that’s more climate friendly.

The study will last about 20 weeks and require 8 visits to the site. Study drugs, study visits, and study-related tests and examinations are provided at no cost.

Participation Criteria

  • Between 18 and 75 years of age
  • Diagnosed with mild to moderate asthma at least 6 months prior to age 50
  • Currently on a stable asthma treatment regimen that includes a daily low- or medium-dose inhaled steroid (with or without a bronchodilator)
  • Non-smoker or former smoker
  • Able to use the study inhaler without a spacer

What is Asthma?

Asthma is a chronic respiratory condition in which the airways become inflamed, narrowed, and produce excess mucus, making breathing difficult. Common symptoms include wheezing, shortness of breath, chest tightness, and coughing, particularly at night or during physical activity. It’s often triggered by allergens, cold air, exercise, respiratory infections, or irritants such as smoke and pollution. While there’s no cure, asthma is typically managed with reliever and preventer inhalers, trigger avoidance, and a personalised action plan developed with a healthcare professional. Severity varies widely, from mild and occasional symptoms to severe cases requiring ongoing medical care.

Find out more: 

Complete the enquiry form and a member of staff will be in contact to discuss further.

Call us on 028 9027 8380 to discuss with the team.